jeff smith starboard news

Pfizer, Starboard Value

Starboard Value CEO Jeff Smith: Pfizer needs to do a better job disciplining itself on investments

Jeff Smith, Starboard Value CEO, joins CNBC's 'Squawk on the Street' to discuss how he sees Pfizer going forward, potential for growth in Kenvue, and more.

Wall Street Journal · 1d

Starboard Chief Criticizes Pfizer’s R&D Investments

Activist hedge fund Starboard Value believes the root cause of Pfizer’s issues are the low expected returns on its research and development investments, including investments done both internally and through mergers and acquisitions.

Reuters on MSN · 1d

Starboard Value CEO says Pfizer's board should hold management accountable

Activist hedge fund Starboard Value's chief investment officer Jeffrey Smith said on Tuesday that drugmaker Pfizer Inc's board needs to hold management accountable for its underperformance. "We measure success in producing blockbuster drugs and we all get measured by our track records.

Starboard, Kenvue

Barron's on MSN · 1d

Starboard Makes Its Case to Shake-Up Pfizer and Kenvue

Starboard has a $1 billion stake in Pfizer and an unknown but "sizable" stake in Kenvue, according to earlier media reports.

Business Insider · 1d

JPMorgan says Starboard aligns with view on Kenvue shares

JPMorgan analyst Andrea Teixeira keeps an Overweight rating on Kenvue (KVUE) after the Wall Street Journal reported Starboard Value has taken a

Wall Street Journal · 13h

Starboard Focused on Kenvue's Struggling Unit

Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he believes is weighing on the company's overall performance.

What activist hedge fund Starboard wants from Pfizer

Activist investor Starboard met with Pfizer last week. Here's what went down, according to the hedge fund's cofounder and CEO ...

21hon MSN

Kenvue needs to fix its skin, health & beauty segments, Starboard's Jeff Smith says (update)

Kenvue (NYSE:KVUE) needs to focus on fixing its skin, health and beauty segments, Jeff Smith, founder and CEO of activist ...

pharmaphorum9h

Starboard spells out its concerns with Pfizer's direction

Despite that cash windfall, Pfizer has "dramatically underperformed its peers and the market since 2019," according to ...

Starboard calls for Pfizer board to ‘hold management accountable’

Jeff Smith says pharma giant’s returns from recent efforts are ‘not adequate’ in speech at 13D activist investor conference ...

FiercePharma1d

UPDATED: Starboard wants to hold Pfizer leadership 'accountable' for overpaid M&A deals, poor return on R&D investment

Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job.

BioSpace1d

Activist Investor Starboard Takes Aim at J&J Spinoff Kenvue on Heels of $1B Stake in Pfizer

Starboard Value contends that Kenvue, with strong consumer health brands like Tylenol and Listerine, is underperforming its ...

2don MSN

Tylenol Maker Kenvue Stock Surges on Report Starboard Takes 'Sizable Stake'

Activist investor Starboard Value reportedly has taken a large stake in consumer health products maker Kenvue.

FiercePharma2d

Activist investor Starboard sets its sights on J&J spinout Kenvue: WSJ

Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has ...

20h

Starboard urges Pfizer board to ‘hold management accountable’, FT reports

Activist investor Starboard Value urged Pfizer’s (PFE) leadership to do “something different” and hold management accountable ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Pfizer, Starboard Value

Starboard, Kenvue

Related topics